Earlier this month, new FDA Commissioner Robert M. Califf M.D., received a letter in opposition to a new regulation signed into law by Congress banning any vaping products containing synthetic nicotine. The measure was part of the omnibus spending package that President Biden signed in late March.
Synthetic nicotine had until this ban been manufactured and sold legally across the US. The groups are also urging Commissioner Califf to allow small businesses trying to comply with the new restriction, to remain on the market for longer than the 60 stipulated days, as they prepare their marketing applications.
Meanwhile, the Competitive Enterprise Institute (CEI) has just joined the above Coalition. Doing its part is also the the Vapor Trade Association (VTA), who earlier this month set up a meeting with the FDA to present the scientific evidence indicting the public health benefits of endorsing products containing synthetic nicotine.
The VTA takes action against the synthetic nicotine ban
The FDA personnel in attendance at the VTA meeting included over 35 senior leaders, representing seven different offices inside CTP. The VTA held presentations by three Ph.D’s in Organic Chemistry and Physical Analytical Chemistry, in order to frame critical scientific and public policy issues that we believe had not previously been presented to or considered by the FDA.
Moreover, when the synthetic nicotine ban was passed, the VTA immediately began working on a strategy to ensure a viable path for companies which are selling the products.